http://www.thecannabist.co/2017/10/06/cbd-epidiolex-gw-pharmaceuticals-fda-hemp-industry/89387/ As CBD drug Epidiolex moves through FDA’s approval pipeline, the GW Pharmaceuticals product developed for treating certain types of epilepsy is watched cautiously by the hemp industry and optimistically by the medical community.
MANTIS_RECOMMEND = {
property: ’57d817ed1e574e4e310ee2e6′,
render: ‘mantis__recommended__wordpress’
};
var z = document.createElement(“script”);
z.type = “text/javascript”;
z.async = true;
z.src = “//assets.mantisadnetwork.com/recommend.min.js”;
var s = document.getElementsByTagName(‘head’)[0];
s.parentNode.insertBefore(z, s);
The post Race for CBD medication breakthrough: Is pharma firm’s boon the hemp industry’s doom? appeared first on Marijuana News.
Source: MJFeed
Leave A Comment